Search Results - "Freriks, Stephan"
-
1
Acquired and intrinsic resistance to vemurafenib in BRAFV600E‐driven melanoma brain metastases
Published in FEBS open bio (01-01-2024)“…BRAFV600‐mutated melanoma brain metastases (MBMs) are responsive to BRAF inhibitors, but responses are generally less durable than those of extracranial…”
Get full text
Journal Article -
2
Abstract LB-255: Acquired and intrinsic resistance to vemurafenib in BRAFv600e-driven melanoma brain metastases
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Purpose: BRAFV600-mutated melanoma brain metastases (MBMs) are generally responsive to BRAF and MEK inhibitors, albeit that responses are generally less…”
Get full text
Journal Article -
3
DDRE-01. ACQUIRED AND INTRINSIC RESISTANCE TO VEMURAFENIB IN BRAFV600E-DRIVEN MELANOMA BRAIN METASTASES
Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)“…BRAF V600-mutated melanoma brain metastases (MBMs) are responsive to BRAF inhibitors, but clinical responses are less durable than those of extracranial…”
Get full text
Journal Article -
4
Acquired and intrinsic resistance to vemurafenib in BRAF V600E -driven melanoma brain metastases
Published in FEBS open bio (01-01-2024)“…BRAF -mutated melanoma brain metastases (MBMs) are responsive to BRAF inhibitors, but responses are generally less durable than those of extracranial…”
Get full text
Journal Article -
5
Abstract 736: Combining PD1- and CTLA4-inhibiting antibodies with cisplatin or PARP inhibition in an attempt to eradicate BRCA1-deficient mouse mammary tumors
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Solid tumors are usually not eradicated by conventional chemotherapy resulting in disease relapse and mortality. An intriguing example is BRCA-associated…”
Get full text
Journal Article